Cargando…

Rare diseases and orphan drugs: Latvian story

BACKGROUND: Ten years have passed since Latvia became a Member State of the EU in 2004. As a result European regulations, including those related to rare diseases and orphan drugs, have been applied to Latvian legislative system. Orphan diseases have been recognized as a priority area for action in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logviss, Konstantins, Krievins, Dainis, Purvina, Santa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172941/ https://www.ncbi.nlm.nih.gov/pubmed/25231378 http://dx.doi.org/10.1186/s13023-014-0147-z

Ejemplares similares

Impact of orphan drugs on Latvian budget
por: Logviss, Konstantins, et al.
Publicado: (2016)

Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study
por: Logviss, Konstantins, et al.
Publicado: (2018)

Variability of Seed Germination and Dormancy Characteristics and Genetic Analysis of Latvian Avena fatua Populations
por: Ņečajeva, Jevgenija, et al.
Publicado: (2021)

Flavonoids in the Spotlight: Bridging the Gap between Physicochemical Properties and Formulation Strategies
por: Berga, Marta, et al.
Publicado: (2023)

Rare Diseases and Orphan Drugs Accessibility in Bosnia and Herzegovina
por: Guzvic, Vladmiri, et al.
Publicado: (2018)

The portal for rare diseases and orphan drugs
por: Singh, Jatinder
Publicado: (2013)

Adherence Level to Arterial Hypertension Treatment: A Cross-Sectional Patient Survey and Retrospective Analysis of the NHS Prescription Database
por: Gavrilova, Anna, et al.
Publicado: (2021)

Pricing of orphan drugs in oncology and rare diseases
por: Nuijten, Mark, et al.
Publicado: (2020)

The availability and affordability of orphan drugs for rare diseases in China
por: Gong, Shiwei, et al.
Publicado: (2016)

Rare diseases and orphan drugs: 500 years ago
por: Dooms, Marc M.
Publicado: (2015)

The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021)

Educational aspects of rare and orphan lung diseases
por: Alfaro, Tiago M., et al.
Publicado: (2021)

The Latvian language in the digital age
por: Rehm, Georg, et al.
Publicado: (2012)

Influence of Severe Carotid Stenosis on Cognition, Depressive Symptoms and Quality of Life
por: Pucite, Elina, et al.
Publicado: (2017)

The paediatric rheumatologist and orphan disease – a story without happy ending
por: Roszkiewicz, Justyna, et al.
Publicado: (2016)

Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019)

Rare disease patients in India are rarely involved in international orphan drug trials
por: Chakraborty, Monoswi, et al.
Publicado: (2022)

Changes in Cognition, Depression and Quality of Life after Carotid  Stenosis Treatment
por: Pucite, Elina, et al.
Publicado: (2019)

A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act
por: Fermaglich, Lewis J., et al.
Publicado: (2023)

Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives
por: Harris, Emily
Publicado: (2018)

Rare diseases: Canada’s “research orphans”
por: Gupta, Samir
Publicado: (2012)

Will Gene Editing Orphanize Rare Diseases?
por: Mann, Douglas L.
Publicado: (2023)

Assessment of antibiotic prescribing in Latvian general practitioners
por: Dumpis, Uga, et al.
Publicado: (2013)

Nutrient Status among Latvian Children with Phenylketonuria
por: Lubina, Olga, et al.
Publicado: (2023)

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
por: Dunne, Michael W., et al.
Publicado: (2016)

Multidisciplinary approach to treat ruptured abdominal aortic aneurysm into the vena cava
por: Lacis, Aigars, et al.
Publicado: (2020)

Orphans in the Market: The History of Orphan Drug Policy
por: Mikami, Koichi
Publicado: (2019)

Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
por: Bhattacharjee, Sonali, et al.
Publicado: (2018)

To what degree are orphan drugs patient-centered? A review of the current state of clinical research in rare diseases
por: Lanar, Sally, et al.
Publicado: (2020)

Ethical Questions Linked to Rare Diseases and Orphan Drugs – A Systematic Review
por: Kacetl, Jaroslav, et al.
Publicado: (2020)

Criteria to define rare diseases and orphan drugs: a systematic review protocol
por: Abozaid, Ghada Mohammed, et al.
Publicado: (2022)

Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story
por: Burton, Arianna, et al.
Publicado: (2021)

Chemical Profiling and Antioxidant Activity of Tanacetum vulgare L. Wild-Growing in Latvia
por: Šukele, Renāte, et al.
Publicado: (2023)

Evaluation of Oleogels Stabilized by Particles of Birch Outer Bark Extract through a Novel Approach
por: Vitolina, Sanita, et al.
Publicado: (2023)

Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
por: Ries, Markus, et al.
Publicado: (2015)

Salt Consumption in Latvian Population: A Pilot Study
por: Lazda, Ilva, et al.
Publicado: (2018)

Serum and urinary calcium level in Latvian patients with sarcoidosis
por: Ruža, Ieva, et al.
Publicado: (2018)

Factors related to poor adherence in Latvian asthma patients
por: Smits, Dins, et al.
Publicado: (2020)

A Statistical Overview of Bibliodiversity in the Latvian Book Market
por: Ungure, Elza
Publicado: (2022)

Orphan drug: Development trends and strategies
por: Sharma, Aarti, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_q9k7avhlit579klj5daigk4iqk